CareFusion Reports Growth in Infusion, Dispensing and Infection Prevention Businesses

CareFusion Corp., a global medical technology company, has reported its results for the fourth quarter and fiscal year ended June 30, 2011, with highlights including growth in the company's infusion, dispensing and infection prevention businesses.

 

The company also noted its acquisition of pharmacy automation innovator Rowa will enable CareFusion to its Pyxis platform outside the United States, according to a company news release.

 

Revenue for the fourth quarter of fiscal 2011 increased 4 percent to $964 million. Operating income was $149 million and income from continuing operations was $96 million.

 

Revenue for fiscal 2011 increased 2 percent to $3.53 billion. Operating income increased to $496 million and income from continuing operations increased to $291 million.

 

"Looking ahead to fiscal 2012, we will continue to leverage operational efficiencies and reduce complexity across our businesses to drive bottom line growth that outpaces our top line growth," said Kieran Gallahue, chairman and CEO, in the release. "We are expecting revenue growth in a range of 3-5 percent over fiscal 2011 results, representing an improvement over the 2 percent growth we had this year and acceleration over the low single digit growth rates we are seeing in the markets where we participate."

 

Read the news release about the results for CareFusion.

 

More Articles Featuring CareFusion:

CareFusion Acquires Technology to Automate the Segregation of Pharmaceutical Waste

CareFusion Sells International Surgical Products to Medline for $130M

CareFusion Launches Adapter Enabling Uninterrupted Airway Access

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers